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Abstract 
Currently, a microalbumin urine test is an annual test for diabetic patients recommended 
by the American Diabetes Association, but primary care providers are not ordering the 
tests. This may be, in part, attributable to the fact that there are no guidelines for ordering 
microalbumin urine tests. The purpose of this capstone project was to assess providers' 
compliance in identifying the need for the microalbumin urine test for patients with 
diabetes, to develop evidence-based guidelines for monitoring and ordering 
microalbumin urine tests, and to evaluate providers' compliance. Rogers's theory of the 
diffusion of innovation provided the framework for this capstone project. A quantitative, 
descriptive design using a non-parametric paired t-test was used. Data was collected pre- 
and post-evidence based practice guidelines implementation in electronic health records. 
The mean monthly percentage of diabetic patients given microalbumin urine tests pre-
implementation was 66.86 (SD = 4.25; 95% CI = (64.17, 69.56). The mean monthly 
percentage of diabetic patients given microalbumin urine tests post-implementation was 
73.53 (SD = 2.58; 95% CI = (70.32, 76.73). SPSS version 23 (IBM Corp., Armonk, NY). 
The two sample t-test was statistically significant, t (15) = -3.232, p = 0.006). The 
introduction of evidence-based practice guidelines for ordering microalbumin urine tests 
improved provider compliance. 
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Increasing Providers’ Adherence to Ordering Microalbumin Urine Tests 
 
Chapter 1: Nature of the Project and Problem Identification 
Diabetes mellitus is a disease that affects people throughout the world. Diabetic 
nephropathy is one of the major complications of diabetes mellitus. Early detection of 
disease complications and prompt intervention can slow the progression of kidney 
damage caused by diabetes. Approximately one in three adults with diabetes and one in 
five adults with high blood pressure have chronic kidney disease (Centers for Disease 
Control and Prevention, 2014). The National Institute of Diabetes and Digestive and 
Kidney Disease (NIDDK) recommends a set of guidelines for early detection of kidney 
disease, including measuring blood and urine levels to detect changes in kidney function 
to enable appropriate early intervention. The NIDDK guidelines state that people who 
have been living with type 1 diabetes for over five years and those who have type 2 
diabetes must be screened annually for albuminuria (NIDDH, 2012a). The urine albumin-
to-creatinine ratio (UACR) test, also known as the microalbumin test, has been identified 
as an important test for detecting early kidney damage. A microalbumin test result greater 
than 30 mg/d is considered abnormal (NIDDK, 2012a). Treatment can be initiated 
quickly, preventing further kidney damage with early intervention. However, despite the 
recommendation of an annual microalbumin urine test to detect early kidney disease, a 
large number of patients with diabetes have not received orders for this test from their 
primary care providers (Kundu, D., Roy, A., Mandal, T., Bandyopadhyay, U., Ghosh, E., 
& Ray, D. 2013). 
This chapter describes the capstone project problem, purpose, objectives, 
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theoretical framework, nursing practice, health care outcome, literature review, and 
methodology. 
Problem Statement  
Currently, microalbumin urine tests are an annual screening test required by the 
American Diabetes Association (ADA); however, only 30% compliance with providers 
ordering the test over a five-year period was found at a community health clinic. 
Purpose Statement 
The purpose of this capstone project was to assess providers’ compliance in 
ordering microalbumin urine tests for patients with diabetes, to develop evidence-based 
practice (EBP) guidelines for monitoring and ordering microalbumin urine tests, and to 
evaluate whether or not this increased providers’ compliance.  
Project Objectives 
The objectives of this project were as follows: 
 Objective 1: Collaborate with clinic healthcare providers and executives, 
including clinic managers and the information technology department director. 
 Objective 2: Assess existing practices at the community clinic pre-guideline 
implementation. 
 Objective 3: Develop evidence-based, standardized microalbumin testing 
guidelines. 
 Objective 4: Implement the use of guidelines into electronic health records 
(EHR).  
 Objective 5: Evaluate providers’ compliance in ordering microalbumin urine tests 
in EHR post-guideline implementation.  
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Theoretical Foundation 
The theoretical framework selected for this capstone project was Roger’s 
diffusion of innovation theory. 
Rogers’ Diffusion of Innovation Theory  
The underpinning for Everett Rogers’ 1962 theory of the diffusion of innovation 
came from observing the adoption of newly developed hard corn varieties by farmers in 
Iowa. An innovation is a new idea communicated to members of a group. Diffusion is the 
process by which an innovation is communicated and accepted. There are various stages 
of acceptance involving early adopters and late adopters and those who have a hard time 
accepting a new innovation. The theory is further analyzed as below.  
Theory selection support. Rogers’ theory of the diffusion of innovation provided 
the framework for this capstone project. According to Rogers’ theory, people become 
aware of the importance of innovation, such as microalbumin urine tests, and then make a 
decision about whether or not to adopt it or, in this case, to comply with requirements to 
order the tests. An increase in the number of microalbumin urine tests ordered by 
providers indicates acceptance and compliance with new guidelines. Rogers’ theory 
consists of four distinct stages as outlined in Table 1. 
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Table 1  
Stages in the Diffusion of Innovation  
 
Knowledge stage Persuasion stage Decision stage Final stage 
Presentation of 
evidence-based 
practice for 
ordering 
microalbumin 
urine tests for 
diabetes patients. 
Emails to remind providers and 
medical assistants. Persuasion of 
clinic managers to participate and to 
remind health care providers at the 
clinic to comply. Electronic Health 
Records (EHR) alerts for providers. 
Medical assistants mail reminders to 
patients.  
 
Implementation of 
Evidence Based 
Practice (EBP) in 
EHR to monitor 
compliance. 
Reinforce 
knowledge if not 
successful. 
Evaluate providers’ 
use of guidelines 
regarding urine test. 
Compare pre and post 
guidelines for 
compliance.  
Application of theory. According to Pearcey and Draper (1996), Roger’s theory 
of innovation diffusion was not specifically designed for any area but provides a useful 
framework for health care practice changes. The theory of innovation diffusion also helps 
to identify hindrances to changes. Pearcey and Draper noted that there was a lack of 
utilization of research findings in disseminating preoperative discharge instructions to 
patients in a hospital ward. The innovation of protocol for hospital ward staff to follow 
when disseminating preoperative discharge instruction was not new to the staff, but the 
plan was to identify and determine where changes could be made. There were four days 
of persuasion and the decision to try out. The new protocol for the dissemination of preop 
discharge instructions was accepted and carried out successfully for three months. 
Pearcey and Draper acknowledged that Roger’s innovation diffusion was a very useful 
tool in their project. They noted that even the innovation of a new idea did not succeed 
past three months. 
Although most providers understand why microalbumin urine tests are necessary 
for patients with diabetes, the tests are not always ordered. A lack of reminders and 
insufficient emphasis on its importance decrease the frequency of ordering the test. There 
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is a need to set up reminders and guidelines for ordering the test. 
Knowledge stage. This phase is critical because providers become aware of new 
guidelines. The dissemination of EBP guidelines for ordering microalbumin urine tests by 
the clinicians serve as a reminder to order the test. The first step was to use email (see 
Appendix A) to communicate to all providers the importance of ordering microalbumin 
urine tests, including that microalbumin urine tests can detect kidney disorders earlier 
than the estimated glomerular filtration rate blood test. During this stage, it also helped to 
set up reminders for providers and medical assistants.  
Persuasion stage. This stage is when the providers may be convinced by the 
evidence to order microalbumin urine tests more frequently. It was the expectation that a 
well-informed provider would be convinced to use the EBP guidelines and remember to 
order the test. 
Decision stage. In this stage, providers decided whether to accept or reject the 
new recommendation. The number of diabetic patients who received microalbumin urine 
tests were counted 2–3 months after the EBP guidelines were introduced. 
Final stage. During this stage, I evaluated providers’ compliance in ordering the 
microalbumin urine test. The data was compared before and after using the EBP 
guidelines in EHR. The healthcare organization continues to monitor compliance and 
project success.  
Significance of Health Care Practice and Outcome 
This project supported the clinic and its providers by increasing awareness of the 
importance of microalbumin urine tests for diabetic patients in order to monitor and 
prevent target organ damage to the kidney. Providers demonstrated increased adherence 
6 
 
 
 
to the guidelines by ordering microalbumin urine tests more frequently. The project 
benefited diabetic patients by preventing target organ damage when providers followed 
the guidelines, ordered microalbumin urine tests appropriately, and initiated proper 
treatment to slow the progression of kidney damage as necessary. 
Nursing Practice 
The findings from this project will reflect the competency and leadership skills of 
an advanced, doctoral-prepared nurse in applying EBP guidelines for ordering 
microalbumin urine tests for diabetics, testing theories, and putting results into action to 
improve human health in the medical setting. 
The identified steps for ordering the microalbumin urine test influenced nursing 
practice by increasing their adherence to ordering this test and assisting in the 
implementation of evidence-based practices for ordering this test. These changes in 
nursing practice can be preventative for kidney complications of end target organ damage 
and improve patients’ quality of life and quality of care. 
Health Care Outcomes 
Being a leader, the ability to influence providers to accept EBP standards of care 
in ordering urine microalbumin tests will have an impact on healthcare outcomes. 
Providers’ acceptance and compliance with this standard of care will reduce the cost 
burden of kidney damage to the patients and the health care system. The project has 
already improved health care outcomes at the local level as the providers increased their 
compliance in ordering urine microalbumin tests, which reduced the risk of target organ 
damage and the cost of hospitalizations for kidney failure and related costs.  
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The scientific evidence gathered from the findings of this project may influence 
health care outcomes by increasing providers’ adherence to guidelines for ordering the 
microalbumin urine test for diabetic patients and through the implementation of the 
evidence-based practice test guideline in the EHR within the health care organization. 
Health Care Delivery 
The Doctorate of Nursing Practice (DNP) program provides graduates with the 
ability to apply advanced clinical skills to prevent disease and improve the health of 
patients. The project affected health care delivery by introducing guidelines in practice 
setting and reinforcing knowledge about the importance of the test in preventing target 
organ damage. 
Providers’ increased awareness of the importance of the microalbumin urine test 
improved their compliance with delivery of preventative care. The providers became 
aware of the benefits of detecting kidney disorders earlier than the blood test for 
estimated glomerular filtration rate can.  
Health Care Policy 
The organization provides quarterly incentives to providers who meet certain 
criteria for preventative patient care. Rewarding providers who deliver high-quality care 
encourages other providers to remember to do more for diabetes patients, paying 
attention to diabetic care and ordering urine microalbumin for diabetic patients. The 
policy of the clinic is now as follows: 
 Providers order microalbumin urine tests for diabetic patients once yearly. 
 If the test shows abnormal results, providers repeat the test at least two more 
times within three months. 
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 Providers treat patients to prevent further kidney damage or, if there is an 
indication of Stage III kidney disease, they refer patients to nephrology. 
A DNP-prepared nurse must be able to demonstrate leadership skills by critically 
analyzing health care policies that affect consumers and organizations. The increase in 
awareness among health providers that microalbumin urine tests help identify kidney 
damage in diabetic patients may influence health care policy at both the local and 
national levels. The expectation is that findings from this project will lead to a change in 
the health care policies of clinics and a reduction in health care costs. Early identification 
of kidney disease will help reduce treatment expenses as fewer patients will need dialysis 
for kidney complications. The cost benefit of this test may also lead to a change in policy 
regarding whether the frequency of the testing should increase from annually to 
biannually. 
The increase in awareness of the value of the microalbumin urine test by health 
providers has influenced health care policy at local, state, and national policies.  
Summary 
The ability of a DNP-prepared graduate to apply newly developed skills and to 
lead in any health care setting has bridged the gaps and biases that exist in various health 
care industries. DNP-prepared advanced-practice nurses have the necessary skill set to 
function efficiently and expertly, to advocate for changes in health care policy, and to 
lead in always-changing health care settings. The microalbumin urine test plays a major 
role in the early detection of kidney damage. When providers adhere to ordering the 
microalbumin test for diabetic patients to prevent and monitor for kidney complications, 
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the result is proper management of the disease and a positive health care outcome for 
patients and organizations. 
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Chapter 2: Literature Review 
Microalbumin 
Microalbumin is the excretion of albumin in urine as permeated by the glomeruli. 
The presence or loss of albumin in urine indicates the onset of kidney damage. According 
to the Office of Disease Prevention and Health Promotion, one of the goals of Healthy 
People 2020 is to “increase the proportion of persons with diagnosed diabetes who obtain 
an annual urinary microalbumin measurement” (2014, p. 1) to 36.6%. In 2007, the 
percentage of Medicare beneficiaries who were diagnosed with diabetes and received the 
test was 33.3%; by 2012, this number exceeded the target and rose to 42.4% (USDHS, 
2014). Although significant improvement was achieved, this rate of test administration 
falls short of the current recommendation of the ADA, which is an annual measurement 
of urinary microalbumin for patients with type 1 diabetes that has lasted for five years 
and when patients with type 2 diabetes are first diagnosed (2016). Sacks (2011) made a 
similar recommendation: annual testing for individuals five years after the diagnosis of 
type 1 diabetes and at the time of type 2 diabetes diagnosis. The Affordable Care Act has 
required the Secretary of Health and Human Services to develop national priorities for 
standardized quality measurement reporting, to invest in patient safety, and to reward 
providers for high-quality care (National Conference of State Legislatures, 2011). 
For this study, a systematic literature search was performed in the Nursing and 
Allied Health, MEDLINE, Google Scholar, and Cumulative Index to Nursing and Allied 
Health Literature databases. The keywords used for the search were ordering 
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“microalbumin urine test” and “provider compliance”. The most common findings from 
the articles discovered in the search were an increase in orders for microalbuminuria 
urine tests, prevention of microalbuminuria, and provider compliance with ordering tests 
for microalbuminuria. 
The following five papers provided strategies for increasing provider compliance 
and guidelines for ordering microalbumin urine tests. 
Knudsen et al. (2012) noted a lack of proper ordering of microalbumin urine tests. 
Of 2,057 diabetic patients who visited their general practitioner in Denmark during a 12-
month period, only 57% received a microalbumin urine test, whereas 97.6% had their 
plasma evaluated for renal problems. The researchers remarked that this was probably 
due to poor knowledge of the importance of the microalbumin urine test in early 
detection of kidney disorders. The authors concluded that giving feedback to individual 
providers would improve the frequency of their ordering the test. 
Anabtawi and Mathew (2013) performed a two-step, two-year project to improve 
microalbuminuria screening. Step 1 involved the introduction of an electronic system that 
evaluated compliance. Step 2 took place the following year, during which the providers 
were assessed for improvement. During step 1, 69% of the patients with diabetes were 
screened, and during step 2, the percentage rose to 84.8%. The authors concluded that the 
success of the study was due to EHR reminders combined with quality control 
monitoring, which significantly improved provider compliance. 
Umar-Kamara and Tufts (2013) noted significant improvement in the post-
intervention quality of test ordering in their evaluation of providers’ adherence to 
recommended standards of care. The intervention involved EHR reminders for providers 
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and letters from providers to patients, suggesting following up with a laboratory test. 
During the 12 post-intervention weeks, urine microalbumin test ordering increased by 
28% (p < .001). 
In a retrospective chart review, Munroe (2015) found that 1 of 60 reviewed charts 
included an order for microalbumin urine testing. Munroe recommended an increase in 
the measure of quality improvement in ordering the test and stated that there was room 
for improvement. 
Kundu et al. reviewed the relevant literature and mentioned several studies in 
which albuminuria was an early sign of changes in renal function, concluding that 
“Microalbumin is still a largely unrecognized risk factor, and a large proportion of 
individuals are not screened regularly” (2013, p. 219). 
Albuminuria is “an important marker of diabetes nephropathy and a risk factor for 
cardiovascular disease” (Ruilope et al., 2010, p. 424). Ruilope et al. noted that early 
detection and intervention could prevent kidney damage. They noted that 
microalbuminuria signals systemic damage to the glomerular filtering section of the 
kidneys and the epithelial lining of the outer cells of the kidneys. The researchers 
recommended treatment for the prevention of microalbumin and concluded that there was 
no established treatment for preventing microalbumin. The researchers suggested that 
keeping patients’ blood pressure under control by using certain medications and keeping 
blood glucose under control will slow the progression of microalbuminuria. 
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Summary 
Raising awareness among providers about the importance of ordering 
microalbumin urine tests while presenting EBP guidelines and supporting evidence for 
the standard of care suggested in the literature review will improve health care for 
diabetic patients. 
After reviewing the literature, there were the following suggestions for successful 
monitoring and ordering of microalbumin urine tests.  
 Providing individual and group feedback to acknowledge successful monitoring 
and ordering of microalbumin urine tests (Knudsen et al., 2012). 
 Combining electronic health record reminders with quality control of the ordering 
of microalbumin urine tests (Anabtawi & Mathew 2013).  
 Sending reminder letters from providers to patients for follow-ups with that 
included microalbumin urine tests (Umar-Kamara & Tufts, 2013). 
This capstone project applied most of the suggestions above and included other 
strategies, such as posters and gift cards, to encourage provider participation. The 
expectation was to increase provider compliance and raise the percentage from 30% to at 
least 60% at the project site. 
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Chapter 3: Methodology 
Microalbumin urine tests provide information about kidney function and are used 
to detect early kidney disease. The American Diabetes Association (2016) published an 
updated guideline for microalbumin urine tests, recommending that annual urinary 
measure of patients with type 1 diabetes with five years’ or more duration and type 2 
diabetic patients starting at diagnosis. 
Although many clinics have similar guidelines, providers still lack compliance in 
ordering the test for diabetes patients. Initiating evidence-based guidelines on the 
importance of microalbumin urine tests have played a significant role in increasing urine 
test ordering (Knudsen et al., 2012). 
Project Design 
This project obtained descriptive statistical data with the help of the information 
technology analyst at the clinics. Initially, the data collection included a retrospective 
review of providers’ compliance with ordering microalbumin urine tests over the past 
five years. A four- to eight-week period of EHR reminders and emails to providers 
regarding the ordering of the test were followed by a period of data collection to evaluate 
the change in provider compliance. 
Setting. The project was set in a small, inner city with ten clinic units supervised 
by an organization that cares for patients with new and chronic diabetes. The staff 
included osteopaths, medical doctors, physicians’ assistants, nurse practitioners, 
transcriptionists, medical assistants, office managers, billing clerks, and receptionists. 
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Under the clinic’s standard of care for diabetes, patients should be seen every three 
months. 
Inclusion criteria. The participants included MDs, RNs, ARNPs, and PAs caring 
for patients who were diagnosed with type 1 or type 2 diabetes. 
Exclusion criteria. Exclusion criteria included providers who had not, in the past 
five years, cared for a patient diagnosed with type 1 or type 2 diabetes. 
Ethical considerations. Permission from the Nova Southeastern University 
institutional review board was processed after departmental approval of the project. The 
plan was to obtain data that was de-identified with the help of the information technology 
department at the clinic. The project posed minimal or no risk to the subjects because the 
collected data was retrospective and de-identified. Data gathering did not directly involve 
any individual subject or provider. We obtained written permission from the site to obtain 
data through the IT department for analysis of providers’ compliance with ordering urine 
microalbumin tests. 
Project phases/objectives. The objectives of this project were as follows: 
Objective 1: Collaborate with clinic healthcare providers and executives, including 
clinic managers and IT department director. 
Objective 2: Assess existing practices at the community clinic prior to guideline 
implementation. 
Objective 3: Develop EBP microalbumin urine testing guidelines. 
Objective 4: Implement guidelines into EHR. 
Objective 5: Evaluate providers’ compliance in ordering microalbumin urine tests 
after the guidelines have been implemented.  
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The developed guidelines included the following: 
 Providers should order microalbumin urine test for diabetic patients once yearly. 
 Medical assistants should identify the patient, provide a clean container for a 
urine sample, process and label containers with patients’ names, and send the 
containers out to a laboratory for analysis. No test preparation by the patients is 
necessary before collection. 
 If the test has abnormal results, the provider should repeat the test at least two 
more times within three months. 
 Providers should treat patients whose test results are abnormal in order to prevent 
further kidney damage. If there is an indication of Stage III kidney disease, 
patients should be referred to nephrology. 
 Implement guidelines into the electronic health records within four weeks. 
 Evaluate providers’ compliance with ordering urine microalbumin in EHR within 
12 weeks.  
Timeline. 
The estimated timeline for the capstone project was as follows:  
Our collaboration with providers, medical staff, and office staff at the clinic took 
five months. Assessment of the existing practices took two weeks. Developing evidence-
based guidelines took another two weeks. Evaluating providers’ compliance took 
approximately 12 weeks.  
Resources/budget. 
The estimated cost of this capstone project was $731.50, which included travel to 
the clinics, a subscription to the website Grammerly to assist with writing emails and 
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paperwork, posters, and appreciation of medical staff to remind patients to come in for a 
urine test. 
 
Table 2 
Project Resources and Budget  
 
Category Item Description Quantity Total 
Printing material Paper Multi-purpose 
printing paper 
$5 x 2 $10 
 Ink Black/color ink 
cartridge  
$45 x 2 $ 90 
Announcement material Posters 
Reminders 
Hard cardboard 
for posters 
$10 x 8 $80 
Grammarly subscription Software Monthly/quarterly $13/mo. x 8 $104 
Weekly thank you for 
medical staff 
Edibles 
 
Appreciation 
token for staff 
Cookies  
Danish & coffee 
Gift cards 
$20 x 8 
$40 x 1 
$10 x 15 
$160 
$ 40 
$150 
Travel Fuel (60 miles 
round trip) 
3 gal. gas $2.50/gal. 
$7.50 per 
round trip 
$7.5 x 13 = 
$97.50 
Total costs    $731.50 
 
Outcome measures for the objectives of the project were as follows: 
 Objective 1: Collaborate with clinic healthcare providers and executives, 
including clinic managers and IT department director. 
o Outcome measure: The employee buy-in, support and assistance from 
stakeholders was obtained. 
 Objective 2: Assess existing practice at the community clinic pre-guideline 
implementation. 
o Outcome Measure. I obtained permission to assess EHRs for existing 
guidelines, if any. 
 Objective 3: Develop EBP microalbumin urine testing guidelines. 
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o Outcome Measure. The evidence-based guidelines were developed and 
approved by stakeholders.  
 Objective 4: Implement guidelines into her.  
o Outcome Measure. The EBP guidelines were implemented in EHRs. I 
measured the monthly percentage of patients who were given the test 
using data gathered by the IT department from EHRs.  
 Objective 5: Evaluate providers’ compliance in ordering microalbumin in EHR 
post-guideline. 
o Outcome Measure. I continuously measured the monthly percentage 
compliance in EHR.  
 Summary 
This goal of this project was to increasing provider compliance with ordering 
microalbumin urine tests. Ethical approval and permission to undertake the project were 
granted by Nova Southeastern University IRB and the project site’s board of directors. 
The project created minimal or no risk for the human subjects. The project was carried 
out in multiple steps and completed in three to four months. The objectives were 
measured by evaluating the outcomes. The project costs were reasonable.  
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Chapter 4: Results and Discussions 
Urine microalbumin tests measure kidney function and also serve as indicators of 
early kidney complications in diabetic patients. Ordering urine microalbumin tests has 
not been a routine process by primary care providers; therefore, there was no standard 
order in the EHR for this important test. Although there are other ways to monitor kidney 
functions in diabetic patients, the least painful and least expensive is to perform 
microalbumin urine tests once a year. 
The ADA and the NIDDK recommend annual urine microalbumin tests for 
diabetic patients. Primary care providers at health care organizations must comply with 
EBP guidelines for ordering urine microalbumin tests annually and improve the quality of 
care for diabetic patients. The higher the compliance, the better the primary care 
providers can meet state and federal government regulations for meaningful uses and 
incentives.  
Results 
The project was enacted in two phases, planning and implementation/evaluation, 
with data collection for analysis. The purpose of the project was to determine if providers' 
compliance in ordering urine microalbumin tests (i.e., the monthly percentage of diabetic 
patients given microalbumin urine tests) was statistically significantly different during the 
planning phase than during the implementation/evaluation phase. I made this 
determination using a two-sample t-test, and a p-value less than 0.05 indicated 
significance. All analyses were conducted using SPSS (Version 23, IBM). 
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Figure 1. Percentage of diabetic patients tested for urine microalbumin. 
 
The bar chart indicates the monthly percentage of diabetic patients tested for urine 
microalbumin, which is also represented in Table 2.  
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Table 3  
Descriptive statistics of monthly percentage of diabetic patients tested for 
urine microalbumin 
 N Mean (SD) 95% CI Median Min Max Q1 Q3 
Planning phase  12 66.86 
(4.25) 
(64.17, 
69.56) 
67.45 59.06 72.88 63.67 70.63 
Implementation/ 
evaluation phase 
5 (73.53, 
2.58) 
(70.32, 
76.73) 
73.11 71.07 76.56 71.07 76.18 
Note. SD = standard deviation; CI = confidence interval; Q1 = the first quartile; Q3 = the 
third quartile. 
 
The table above shows the monthly percentage of diabetic patients tested for urine 
microalbumin. 
In the planning phase, the mean monthly percentage of diabetic patients tested for 
urine microalbumin was 66.86 [SD = 4.25; 95% CI = (64.17, 69.56)]; in the 
implementation/evaluation phase, the mean monthly percentage of diabetic patients tested 
for urine microalbumin was 73.53 [SD = 2.58; 95% CI = (70.32, 76.73)]. The results of 
the two-sample t-test indicated that there was a statistically significant difference in the 
monthly percentage of diabetic patients tested for urine microalbumin between the 
planning phase and the implementation/evaluation phase [t(15) = -3.232, p = 0.006]. 
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Figure 2. Percentage of diabetic patients tested for microalbumin. 
 
Figure 2 is a box plot of the monthly percentage of diabetic patients tested for 
urine microalbumin during the planning phase and the implementation/evaluation phase. 
In the box plot, the top of the rectangle indicates the third quartile (Q3), the horizontal 
line near the middle of the rectangle indicates the median, and the bottom of the rectangle 
indicates the first quartile (Q1). The upper vertical line extends from the top of the 
rectangle to indicate the maximum value, and the lower vertical line extends from the 
bottom of the rectangle to indicate the minimum value. 
The mean monthly percentage of diabetic patients tested for urine microalbumin 
in the implementation/evaluation phase was statistically significantly higher than that in 
the planning phase. I conclude that the introduction of evidence-based practice guidelines 
for ordering urine microalbumin tests in the EHR improved provider compliance. 
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Discussion of Findings 
A retrospective evaluation of providers’ compliance in ordering microalbumin 
test at a health care organization between 2010 and 2015 was approximately 30%. In 
order to ensure accuracy in data collection, EHRs were used to gather data for the project. 
There was an accumulated monthly compliance percentage score in the EHRs gathered 
from the planning stage starting and ending in January 2016 to the 
implementation/evaluation stage from January 2016 to May 2017. 
The patients benefited from early intervention and prevention of progression of 
kidney disease to kidney failure. Providers were assisted in initiating patient education by 
early detection of kidney disorders that included tight blood glucose control and other 
treatment plans to prevent further kidney damage.  
The findings from this project informed a health care organization that primary 
care providers can improve the quality of care for diabetic patients by increased 
compliance in ordering urine microalbumin tests, as recommended by the ADA. The 
success of this project was based on team support, electronic mail reminders, project 
presentation, poster advertisement, and recall of diabetic patients for follow-up 
appointments.  
Expected/Unexpected Findings. The expected findings of this project included an 
increase in providers' compliance and improved quality care for diabetic patients at the 
health care organization, which decreased early progression of kidney complications. The 
unexpected findings were that when tests are ordered in the EHR, providers and medical 
assistants must review and finalize the orders. Otherwise, the urine microalbumin test 
will not be marked as completed in the patient’s EHR. This situation was caught and 
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addressed, and the clinic managers sent reminders to medical assistants on a monthly 
basis to make sure that the test was reviewed and completed by providers. 
Strengths/Limitations of the Project 
The strengths of the project were the team effort, the support from stakeholders, 
and the professional collaboration that moved the project forward. A limitation of the 
project was provider instability. A significant number of providers were lost on a yearly 
basis from the clinics. The loss of providers affects patients' continuity of diabetic care. It 
was difficult to measure individual provider compliance, and the opportunity to find out 
if a provider might be negatively effecting the compliance rate for the group was missed. 
Implication for Practice 
Nursing practice. The findings from this project will reflect the competency and 
leadership skills of an advanced, doctoral-prepared nurse in applying evidence-based 
practice guidelines for ordering microalbumin urine tests for patients with diabetes, 
testing theories, and putting results into practice to improve human health. 
The identified steps for ordering the microalbumin urine test influenced nursing 
practice by increasing providers' adherence to ordering this test and assisting in the 
implementation of EBP guidelines for ordering this test. These changes in nursing 
practice can prevent kidney complications and improve patients' quality of life and 
quality of care. 
Health care outcomes. As a leader, the ability to influence providers to accept 
the EBP guidelines will impact healthcare outcomes. Providers' acceptance and 
compliance with this standard of care will reduce the cost burden of kidney damage to the 
patient and the health care system. 
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The project has improved health care outcomes at the local level, as providers 
increased compliance in ordering microalbumin urine tests and thereby reduced the risk 
of target organ damage and the cost of hospitalization for kidney failure and related costs. 
The scientific evidence gathered from the findings of this project may influence health 
care outcomes by increasing providers' adherence to guidelines for ordering 
microalbumin urine tests for diabetic patients and through the implementation of the EBP 
guidelines within the health care organization. 
Health care delivery. The DNP program provides graduates with the ability to 
apply advanced clinical skills for disease prevention and improvement of patient health. 
The project affected health care delivery by introducing current guidelines in a practice 
setting and reinforcing knowledge about the importance of microalbumin urine tests in 
preventing organ damage. 
Future research. A recommendation for future research is to obtain permission 
to review individual provider compliance and then compare improvement from 
pretreatment to posttreatment of the patient. A monthly email reminder, poster 
advertisements, and celebrations of success with incentives encourage health care 
providers to participate and improve quality of care for diabetic patients.  
Summary 
Microalbumin urine tests are important for diabetic patients, as well as being 
inexpensive and highly recommended by the ADA. The federal government set a target 
goal for this valuable urine test that health care organizations must attempt to achieve. 
The goal is 37% of diabetic patients will receive an annual microalbumin urine test by 
2020. The health care organization met the goal and currently has a mean value of 74% 
26 
 
 
 
and needs continue complying. Health care providers must familiarize themselves with 
the EHR to make sure that diabetes patients receive annual microalbumin urine tests. 
Health care organizations must continue to encourage primary care providers to 
participate in promoting quality care and continue to offer incentives for projects. The use 
of the EHRs could not be overemphasized as it helps assess, implement, and evaluate the 
care provided. The EHRs also have data to identify problems that need to be addressed 
and resolved to improve the quality of care delivered to the patients. For a DNP graduate, 
leadership in health care industries is an invaluable skill for which they have been 
prepared by the DNP program. Being able to lead this project to a successful outcome is 
attributed to the efforts of all involved and the Nova Southeastern University DNP 
program.  
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Appendix B 
 
Monthly Data Score for Collection of Urine Microalbumin in EHR 
 
 
Number of 
diabetic patients 
tested monthly  
Number of 
diabetic patients 
seen monthly 
Percentage of 
diabetic patients 
tested monthly  
Jan-16 87 128 68.0% 
 Feb-16 87 130 66.9% 
 Mar-16 82 129 63.6% 
 Apr-16 79 129 61.2% 
 May-
16 75 127 59.1% 
 Jun-16 80 125 64.0% 
 Jul-16 81 123 65.9% 
 Aug-16 84 122 68.9% 
 Sep-16 84 120 70.0% 
 Oct-16 84 118 71.2% 
 Nov-16 86 118 72.9% 
 Dec-16 85 120 70.8% 
 Jan-17 86 121 71.1% 
 Feb-17 86 121 71.1% 
 Mar-17 87 119 73.1% 
 April-
17 94 124 75.8%  
May-
17 98 128 76.2%  
 
 
